MoonLake Immunotherapeutics (MLTX) Goodwill & Intangibles (2020)

MoonLake Immunotherapeutics (MLTX) recorded quarterly Goodwill & Intangibles of $5.0 million in Q4 2020.

MoonLake Immunotherapeutics (MLTX) Goodwill & Intangibles (2020) Analysis & Trends

MoonLake Immunotherapeutics' Goodwill & Intangibles history runs 1 years deep, the most recent figure standing at $5.0 million for Q4 2020.

  • In Q4 2020, Goodwill & Intangibles changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2020 stood at $5.0 million (changed N/A YoY), while the FY2020 annual figure was $5.0 million, changed N/A from the prior year.
  • Goodwill & Intangibles was $5.0 million for Q4 2020 at MoonLake Immunotherapeutics.
  • In the past five years, Goodwill & Intangibles ranged from a high of $5.0 million in Q4 2020 to a low of $5.0 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 MoonLake Immunotherapeutics 1.25 Bn 888.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 5.00 Mn